Increasing recruitment of older cancer patients for clinical trials seems to be one goal of the FDA's new performance status eligibility draft guidance. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
